Company news
Voyageur Pharmaceuticals Ltd (TSXV:VM) news
Voyageur Pharmaceuticals Ltd news releases on 6ix. Latest, Oct 2, 2026: Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
Press releases & updates
Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
October 2, 2026
Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt
September 24, 2026
(PODCAST) Voyageur Pharmaceuticals (TSXV:VM) Achieves First Milestone in Bayer Collaboration, Secures USD $1 Million Payment
September 10, 2026
Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment
September 9, 2026
Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process With 99.8% Purity Results and Planned Field Pilot Testing
August 10, 2026
Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
July 17, 2026
Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility
June 23, 2026
Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway
June 18, 2026
Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project
June 10, 2026
Voyageur Announces Closing Of Non-Brokered Private Placement Pursuant To Listed Issuer Financing Exemption
June 5, 2026
Voyageur Announces Filing Of Amended And Restated Offering Document
May 28, 2026
Voyageur Announces Update To Non-Brokered Life Offering
May 1, 2026
Voyageur Announces Shares for Debt Settlement and Stock Option Repricing
April 17, 2026
Voyageur Announces Non-Brokered Life Offering
March 25, 2026
Voyageur Announces Advancements on its Barium & Iodine Contrast Media Projects
March 16, 2026
Voyageur Pharmaceuticals : Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant
March 5, 2026
Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial With Alberta Innovates Grant; Announces Stock Option and DSU Grants, and Proposed Issuance of Securities for Debt
March 4, 2026
Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt
March 4, 2026
Voyageur Pharmaceuticals Announces Collaboration With Bayer
February 23, 2026
Voyageur Pharmaceuticals Announces Collaboration with Bayer
February 23, 2026
Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology
January 12, 2026
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors With Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion
November 7, 2025
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion
November 7, 2025
Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement With PHALANX
October 29, 2025
Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement with PHALANX
October 29, 2025
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Wall Street Expertise to Facilitate U.S. Market Expansion
October 23, 2025
Voyageur Pharmaceuticals Launches U.S. Iodine Feasibility Study to Establish First Fully Integrated North American Contrast Drug Manufacturing Platform
August 25, 2025
Voyageur Pharmaceuticals Initiates First Commercial Shipments of Barium Contrast Products to Canadian Clinics
August 21, 2025
Voyageur Pharmaceuticals Announces Exercise of Warrants for Gross Proceeds of $1.69 Million
August 19, 2025
Voyageur Advances Frances Creek Barite Project With VAST Engagement for Bulk Sample Permit
August 18, 2025
Voyageur Advances Frances Creek Barite Project with VAST Engagement for Bulk Sample Permit
August 18, 2025
Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants
July 14, 2025
Voyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market Expansion
June 24, 2025
Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain
June 23, 2025
Voyageur Enters Revenue Stage With First Commercial Sale of Barium Contrast Agents
June 4, 2025
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
June 4, 2025
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
May 12, 2025
Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant
May 1, 2025
Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results
April 23, 2025
Voyageur Pharmaceuticals Grants Deferred Share Units
April 7, 2025
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
April 1, 2025
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
March 4, 2025
Voyageur Clarifies Terms of Previously Announced Agreement
March 3, 2025
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
February 18, 2025
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
February 5, 2025
Voyageur Secures $687k of Additional Capital from Warrant Exercises
January 23, 2025
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
January 15, 2025
Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch
January 13, 2025
Canadian Investment Regulatory Organization Trade Resumption - VM
December 20, 2024
Voyageur Pharmaceuticals Ltd. Signs Letter of Intent with Global Contrast Imaging Company to Expand Market Reach and Product Portfolio
December 20, 2024